PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.07%
Revenue growth under 50% of NXPI's 3.21%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-6.06%
Negative gross profit growth while NXPI is at 0.13%. Joel Greenblatt would examine cost competitiveness or demand decline.
-10.44%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-10.44%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-4.25%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-4.44%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-2.27%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-1.21%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.72%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
0.46%
Dividend growth above 1.5x NXPI's 0.12%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
102.70%
OCF growth above 1.5x NXPI's 37.88%. David Dodd would confirm a clear edge in underlying cash generation.
243.37%
FCF growth above 1.5x NXPI's 94.26%. David Dodd would verify if the firm’s strategic investments yield superior returns.
91.91%
10Y revenue/share CAGR 1.25-1.5x NXPI's 79.10%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
76.29%
5Y revenue/share CAGR similar to NXPI's 77.31%. Walter Schloss might see both companies benefiting from the same mid-term trends.
17.50%
Positive 3Y CAGR while NXPI is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
123.71%
10Y OCF/share CAGR 1.25-1.5x NXPI's 104.58%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
171.96%
5Y OCF/share CAGR above 1.5x NXPI's 107.18%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
-13.46%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
311.00%
Net income/share CAGR above 1.5x NXPI's 36.73% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
66.06%
Below 50% of NXPI's 328.95%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
11.12%
Positive short-term CAGR while NXPI is negative. John Neff would see a clear advantage in near-term profit trajectory.
100.48%
Below 50% of NXPI's 1254.96%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
16.45%
5Y equity/share CAGR at 75-90% of NXPI's 18.89%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
5.88%
Below 50% of NXPI's 42.98%. Michael Burry suspects a serious short-term disadvantage in building book value.
361.29%
Dividend/share CAGR of 361.29% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
366.79%
5Y dividend/share CAGR above 1.5x NXPI's 169.49%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
652488.96%
3Y dividend/share CAGR above 1.5x NXPI's 20.43%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-2.04%
Firm’s AR is declining while NXPI shows 1.04%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-4.60%
Inventory is declining while NXPI stands at 0.47%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
0.68%
Asset growth above 1.5x NXPI's 0.28%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
2.34%
50-75% of NXPI's 3.20%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
3.89%
R&D growth drastically higher vs. NXPI's 4.75%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-8.88%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.